Logo image of VRAP.PA

VRANKEN - POMMERY MONOPOLE (VRAP.PA) Stock Fundamental Analysis

Europe - EPA:VRAP - FR0000062796 - Common Stock

11.45 EUR
-0.35 (-2.97%)
Last: 10/9/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to VRAP. VRAP was compared to 26 industry peers in the Beverages industry. While VRAP is still in line with the averages on profitability rating, there are concerns on its financial health. VRAP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year VRAP was profitable.
In the past year VRAP had a positive cash flow from operations.
VRAP had positive earnings in each of the past 5 years.
VRAP had a positive operating cash flow in each of the past 5 years.
VRAP.PA Yearly Net Income VS EBIT VS OCF VS FCFVRAP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

VRAP has a Return On Assets of 0.11%. This is amonst the worse of the industry: VRAP underperforms 80.77% of its industry peers.
VRAP has a worse Return On Equity (0.36%) than 80.77% of its industry peers.
VRAP has a Return On Invested Capital of 2.01%. This is amonst the worse of the industry: VRAP underperforms 92.31% of its industry peers.
VRAP had an Average Return On Invested Capital over the past 3 years of 2.15%. This is significantly below the industry average of 8.66%.
Industry RankSector Rank
ROA 0.11%
ROE 0.36%
ROIC 2.01%
ROA(3y)0.44%
ROA(5y)0.39%
ROE(3y)1.41%
ROE(5y)1.26%
ROIC(3y)2.15%
ROIC(5y)1.97%
VRAP.PA Yearly ROA, ROE, ROICVRAP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5 2 2.5

1.3 Margins

VRAP has a Profit Margin of 0.46%. This is amonst the worse of the industry: VRAP underperforms 80.77% of its industry peers.
VRAP's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 10.98%, VRAP is not doing good in the industry: 73.08% of the companies in the same industry are doing better.
VRAP's Operating Margin has improved in the last couple of years.
VRAP has a Gross Margin (49.69%) which is comparable to the rest of the industry.
VRAP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.98%
PM (TTM) 0.46%
GM 49.69%
OM growth 3Y6.3%
OM growth 5Y8.09%
PM growth 3Y-50.55%
PM growth 5Y61.17%
GM growth 3Y3.29%
GM growth 5Y-0.37%
VRAP.PA Yearly Profit, Operating, Gross MarginsVRAP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VRAP is destroying value.
VRAP has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for VRAP remains at a similar level compared to 5 years ago.
The debt/assets ratio for VRAP is higher compared to a year ago.
VRAP.PA Yearly Shares OutstandingVRAP.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
VRAP.PA Yearly Total Debt VS Total AssetsVRAP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

VRAP has an Altman-Z score of 0.79. This is a bad value and indicates that VRAP is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of VRAP (0.79) is worse than 92.31% of its industry peers.
VRAP has a debt to FCF ratio of 46.54. This is a negative value and a sign of low solvency as VRAP would need 46.54 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 46.54, VRAP is doing worse than 80.77% of the companies in the same industry.
VRAP has a Debt/Equity ratio of 1.50. This is a high value indicating a heavy dependency on external financing.
VRAP has a Debt to Equity ratio of 1.50. This is in the lower half of the industry: VRAP underperforms 73.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF 46.54
Altman-Z 0.79
ROIC/WACC0.44
WACC4.59%
VRAP.PA Yearly LT Debt VS Equity VS FCFVRAP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

VRAP has a Current Ratio of 1.75. This is a normal value and indicates that VRAP is financially healthy and should not expect problems in meeting its short term obligations.
VRAP has a better Current ratio (1.75) than 65.38% of its industry peers.
VRAP has a Quick Ratio of 1.75. This is a bad value and indicates that VRAP is not financially healthy enough and could expect problems in meeting its short term obligations.
VRAP's Quick ratio of 0.16 is on the low side compared to the rest of the industry. VRAP is outperformed by 96.15% of its industry peers.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 0.16
VRAP.PA Yearly Current Assets VS Current LiabilitesVRAP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2

3. Growth

3.1 Past

VRAP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -77.60%.
VRAP shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 64.31% yearly.
Looking at the last year, VRAP shows a decrease in Revenue. The Revenue has decreased by -8.01% in the last year.
The Revenue has been growing slightly by 2.05% on average over the past years.
EPS 1Y (TTM)-77.6%
EPS 3Y-50.41%
EPS 5Y64.31%
EPS Q2Q%25.79%
Revenue 1Y (TTM)-8.01%
Revenue growth 3Y0.3%
Revenue growth 5Y2.05%
Sales Q2Q%-0.21%

3.2 Future

Based on estimates for the next years, VRAP will show a small growth in Earnings Per Share. The EPS will grow by 5.43% on average per year.
Based on estimates for the next years, VRAP will show a decrease in Revenue. The Revenue will decrease by -0.15% on average per year.
EPS Next Y-38.28%
EPS Next 2Y-3.58%
EPS Next 3Y5.43%
EPS Next 5YN/A
Revenue Next Year-5.93%
Revenue Next 2Y-1.76%
Revenue Next 3Y-0.15%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
VRAP.PA Yearly Revenue VS EstimatesVRAP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
VRAP.PA Yearly EPS VS EstimatesVRAP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

2

4. Valuation

4.1 Price/Earnings Ratio

VRAP is valuated quite expensively with a Price/Earnings ratio of 71.56.
Based on the Price/Earnings ratio, VRAP is valued more expensive than 84.62% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.70. VRAP is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 18.87, which indicates a rather expensive current valuation of VRAP.
VRAP's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. VRAP is more expensive than 65.38% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.15, VRAP is valued at the same level.
Industry RankSector Rank
PE 71.56
Fwd PE 18.87
VRAP.PA Price Earnings VS Forward Price EarningsVRAP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VRAP indicates a slightly more expensive valuation: VRAP is more expensive than 76.92% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, VRAP is valued cheaper than 88.46% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.21
EV/EBITDA 14.91
VRAP.PA Per share dataVRAP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.11
EPS Next 2Y-3.58%
EPS Next 3Y5.43%

5

5. Dividend

5.1 Amount

VRAP has a Yearly Dividend Yield of 6.61%, which is a nice return.
VRAP's Dividend Yield is rather good when compared to the industry average which is at 3.01. VRAP pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, VRAP pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.61%

5.2 History

Dividend Growth(5Y)0%
Div Incr Years0
Div Non Decr Years3
VRAP.PA Yearly Dividends per shareVRAP.PA Yearly Dividends per shareYearly Dividends per share 2019 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

509.83% of the earnings are spent on dividend by VRAP. This is not a sustainable payout ratio.
DP509.83%
EPS Next 2Y-3.58%
EPS Next 3Y5.43%
VRAP.PA Yearly Income VS Free CF VS DividendVRAP.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M
VRAP.PA Dividend Payout.VRAP.PA Dividend Payout, showing the Payout Ratio.VRAP.PA Dividend Payout.PayoutRetained Earnings

VRANKEN - POMMERY MONOPOLE

EPA:VRAP (10/9/2025, 7:00:00 PM)

11.45

-0.35 (-2.97%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)09-11 2025-09-11
Earnings (Next)01-29 2026-01-29
Inst Owners0.73%
Inst Owner ChangeN/A
Ins Owners71.03%
Ins Owner ChangeN/A
Market Cap102.36M
Analysts44
Price Target13.11 (14.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.61%
Yearly Dividend0.8
Dividend Growth(5Y)0%
DP509.83%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-6.55%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-60.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.8%
Valuation
Industry RankSector Rank
PE 71.56
Fwd PE 18.87
P/S 0.34
P/FCF 6.21
P/OCF 3.61
P/B 0.26
P/tB 0.37
EV/EBITDA 14.91
EPS(TTM)0.16
EY1.4%
EPS(NY)0.61
Fwd EY5.3%
FCF(TTM)1.84
FCFY16.1%
OCF(TTM)3.17
OCFY27.71%
SpS33.98
BVpS43.79
TBVpS30.54
PEG (NY)N/A
PEG (5Y)1.11
Profitability
Industry RankSector Rank
ROA 0.11%
ROE 0.36%
ROCE 3.72%
ROIC 2.01%
ROICexc 2.02%
ROICexgc 2.28%
OM 10.98%
PM (TTM) 0.46%
GM 49.69%
FCFM 5.42%
ROA(3y)0.44%
ROA(5y)0.39%
ROE(3y)1.41%
ROE(5y)1.26%
ROIC(3y)2.15%
ROIC(5y)1.97%
ROICexc(3y)2.17%
ROICexc(5y)2.01%
ROICexgc(3y)2.46%
ROICexgc(5y)2.31%
ROCE(3y)3.55%
ROCE(5y)3.25%
ROICexcg growth 3Y-6.14%
ROICexcg growth 5Y11.64%
ROICexc growth 3Y-4.42%
ROICexc growth 5Y11.55%
OM growth 3Y6.3%
OM growth 5Y8.09%
PM growth 3Y-50.55%
PM growth 5Y61.17%
GM growth 3Y3.29%
GM growth 5Y-0.37%
F-Score4
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF 46.54
Debt/EBITDA 12.57
Cap/Depr 88.19%
Cap/Sales 3.91%
Interest Coverage 250
Cash Conversion 60.57%
Profit Quality 1182.07%
Current Ratio 1.75
Quick Ratio 0.16
Altman-Z 0.79
F-Score4
WACC4.59%
ROIC/WACC0.44
Cap/Depr(3y)114.75%
Cap/Depr(5y)104.39%
Cap/Sales(3y)5.1%
Cap/Sales(5y)5.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-77.6%
EPS 3Y-50.41%
EPS 5Y64.31%
EPS Q2Q%25.79%
EPS Next Y-38.28%
EPS Next 2Y-3.58%
EPS Next 3Y5.43%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.01%
Revenue growth 3Y0.3%
Revenue growth 5Y2.05%
Sales Q2Q%-0.21%
Revenue Next Year-5.93%
Revenue Next 2Y-1.76%
Revenue Next 3Y-0.15%
Revenue Next 5YN/A
EBIT growth 1Y-22.84%
EBIT growth 3Y6.63%
EBIT growth 5Y10.31%
EBIT Next Year24.69%
EBIT Next 3Y10.4%
EBIT Next 5YN/A
FCF growth 1Y-52.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-45.77%
OCF growth 3Y-37.15%
OCF growth 5Y55.04%